Companies: 10,795·Total market cap: $144.5T
Nutra Pharma Corp.

Nutra Pharma Corp.

NPHCOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$1431945
P/E Ratio
52W High$0.005
52W Low$0.0001
Overview

Nutra Pharma Corp. (NPHC) Revenue

Annual & quarterly revenue history · segment & region breakdown

NPHC · revenue · updated Jun 9, 2026

Core revenue metrics

Nutra Pharma Corp. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.

TTM revenue
$0.00B
4-quarter sum · USD
YoY growth
+0.00%
vs FY
Price / sales
mktCap ÷ TTM rev
Revenue per day
Est. TTM ÷ 365
Revenue / employee
$0K
4 employees
FY
FY
5Y CAGR
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · Nutra Pharma Corp. SEC filings · GAAPUpdated: 2026-06-09

Revenue trend

· Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
NPHC revenue by year · NPHC revenue history · NPHC annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income Nutra Pharma Corp. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

Nutra Pharma Corp. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from Nutra Pharma Corp.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

NPHC revenue · 4 questions

NPHC's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.

NPHC revenueNPHC annual revenuewhat is NPHC revenueNPHC TTM revenue

Source: FMP · Nutra Pharma Corp. SEC filings · GAAP · Nutra Pharma Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026